Lexicon Pharmaceuticals, Inc. announced that Viatris Inc. has obtained an exclusive license from Lexicon to commercialize sotagliflozin outside of the United States and Europe...
Viatris Inc., a global healthcare company, announced that, as it prepares to enter Phase 2 of its strategic plan, Theodora "Doretta" Mistras has been...